BackSirona Biochem Overview

Sirona Biochem Long Term Debt

Sirona Biochem's long-term debt is $1.8M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$1.78M
↑ 13.93% YoYΔ $217411.00 vs prior year quarter

Peer trimmed avg / median

Loading

Sirona Biochem Long Term Debt History

Loading

Sirona Biochem vs. peers: Long Term Debt Comparison

Loading

Sirona Biochem Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sirona Biochem (SRBCF) FAQ

Sirona Biochem (SRBCF) currently reports a long-term debt of $1.8M as of July 2024. That compares with $1.6M in the prior-year period — up 13.9% year over year. Use the charts on this page to explore Sirona Biochem's long-term debt history and peer comparisons.

Sirona Biochem's long-term debt increased from $1.6M to $1.8M — a 13.9% year-over-year increase (period ending July 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sirona Biochem reported $1.8M in long-term debt as of July 2024. That compares with $1.6M in the prior-year period — up 13.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $1.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sirona Biochem, and consider following SRBCF for alerts when major investors trade the stock.

Sirona Biochem is classified in the Healthcare sector. On long-term debt, it currently shows $1.8M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SRBCF with unrelated industries.